269 results
Page 6 of 14
8-K
EX-99.1
m1kha5g73qj oe00kmw
21 Aug 13
BioTime Announces the Appointment of Lesley Stolz as Executive Vice President of Corporate Development
12:00am
8-K
EX-99.1
ot0xorec
5 Aug 13
BioTime’s Subsidiary OncoCyte Corporation Publishes Data on the Gene FSIP1 as a Breast Cancer-Specific Marker
12:00am
424B3
51cos3w2mvd
2 Aug 13
Prospectus supplement
12:00am
8-K
EX-99.1
8glmmu 3iwmk
16 Jul 13
BioTime CEO Dr. Michael West to Present at the Case Western Reserve University 6th Annual Regenerative Medicine Business Education Course
12:00am
8-K
EX-99.1
7kl7u
12 Jun 13
BioTime Appoints Henry L. Nordhoff to Board of Directors
12:00am
8-K
EX-99.1
z7flskusj5h
7 Jun 13
BioTime, Inc. Closes on $9 Million Financing
12:00am
424B5
dvdru 8k264jzc3t5
3 Jun 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
95gm xf9evs42v8
3 Jun 13
BioTime, Inc. to Raise $9 Million in Registered Direct Offering
12:00am
8-K
EX-99.1
8vk1ct35jn lfpyd
23 May 13
BioTime Announces Results of Vote at Special Meeting of Shareholders
12:00am
8-K
EX-99.1
z6qr6061ep7hcp8lfk
30 Apr 13
BioTime Announces CFO Succession Plan
12:00am
8-K
EX-99.1
rpj0nezac7e4z875 qcd
23 Apr 13
LifeMap Sciences, a Subsidiary of BioTime, Announces Partnership with Appistry
12:00am
8-K
EX-99
i9sn 3moopdjtwc69zt
19 Apr 13
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
12:00am
8-K
EX-99.1
u991xbca00gt0z0d4
10 Apr 13
LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene
12:00am
8-K
EX-99.1
6j3v68p1
25 Mar 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
nijagp vpilox2a3
18 Mar 13
BioTime Announces Fourth Quarter and Fiscal Year End 2012 Financial Results and Recent Corporate Accomplishments
12:00am